Goal-directed Hemodynamic Management and Acute Kidney Injury After Radical Nephrectomy
Renal Cell Carcinoma, Nephrectomy, Hemodynamic Management
About this trial
This is an interventional prevention trial for Renal Cell Carcinoma focused on measuring Renal Cell Carcinoma, Nephrectomy, Hemodynamic Management, Acute Kidney Injury, Chronic Kidney Diseases
Eligibility Criteria
Inclusion criteria:
- Age of 18 years or older;
- Scheduled to undergo radical nephrectomy for renal cancer.
Exclusion criteria
- Refused to participate;
- Diagnosed with chronic kidney disease (stage 3 or higher) before surgery;
- Uncontrolled severe hypertension (systolic blood pressure ≥180 mmHg or diastolic blood pressure ≥110 mmHg);
- Unable to communicate due to severe dementia, language barrier, or end-stage disease before surgery;
- Enrolled in other trials;
- Other conditions that are considered unsuitable for inclusion (specific reasons should be indicated).
Sites / Locations
- Beijing University First Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Targeted blood pressure management
Routine care
During anesthesia, mean blood pressure is maintained ≥85 mmHg or above baseline by combining fluid challenge and norepinephrine infusion; For patients admitted to intensive care unit after surgery, mean blood pressure is maintained ≥85 mmHg or above baseline by combining fluid challenge and norepinephrine infusion; In the general ward, systolic blood pressure is maintained ≥110 mmHg or within 10% of baseline by delaying antihypertensive resumption, providing fluid challenge, and/or norepinephrine infusion.
During anesthesia, mean blood pressure is maintained ≥65 mmHg or within 20% of baseline according to routine practice; For patients admitted to intensive care unit, mean blood pressure is maintained ≥65 mmHg or within 20% of baseline according to routine practice; In the general ward, management is performed according to routine practice.